Oct 6, 2026 07:30PM
May 18, 2026 08:00AM
May 14, 2026 10:55AM
Apr 20, 2026 06:45AM
Apr 20, 2026 06:45AM
Feb 27, 2026 10:04AM
Feb 27, 2026 10:00AM PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
Dec 17, 2025 06:45AM
Nov 21, 2025 01:24PM
Nov 21, 2025 01:24PM
Oct 21, 2025 07:30PM
Oct 21, 2025 07:30PM
Oct 18, 2025 10:30AM
Oct 1, 2025 02:00AM Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025
Aug 12, 2025 05:30AM
Feb 10, 2025 05:01PM
Feb 10, 2025 05:00PM
Jan 30, 2024 09:00PM
Jan 26, 2024 12:01PM
Jan 26, 2024 12:00PM
Jan 26, 2024 12:00PM European Medicines Agency Validates Type II Variation Application for PADCEV™ (enfortumab vedotin) with KEYTRUDA®(pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Dec 21, 2023 06:30PM
Nov 15, 2023 06:37PM
Aug 7, 2023 09:00AM
Jul 11, 2023 07:00PM
May 1, 2023 09:16AM
Apr 30, 2023 09:24PM
Apr 30, 2023 07:00PM Astellas Enters into Definitive Agreement to Acquire Iveric Bio
Jan 23, 2023 06:30PM
Oct 24, 2022 07:30PM
Oct 24, 2022 07:30PM
Jun 8, 2022 08:00AM
Feb 7, 2022 06:00PM
Dec 1, 2021 07:00PM
Jul 30, 2021 08:00AM Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs
Oct 20, 2020 08:00AM
Oct 14, 2020 11:00PM
Jan 15, 2020 08:22AM
Jan 14, 2020 02:07AM
Dec 26, 2019 07:30PM
Oct 28, 2019 09:00AM
Feb 28, 2019 05:34PM Astellas Announces Key Leadership Promotions and New Hire in Legal, IP and Immuno-Oncology
Dec 14, 2018 01:00PM
Aug 10, 2018 07:00AM
Apr 25, 2018 11:00PM
Feb 13, 2018 08:00PM
Jan 30, 2018 10:00PM
Jan 23, 2018 09:00PM
Nov 30, 2017 07:00PM Astellas Acquires Mitobridge Under Existing Collaboration
Oct 19, 2017 09:00PM

1,200,876 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All